Calithera Biosciences Inc. (NASDAQ: CALA) stock closed at 2.6 per share at the end of the most recent trading day (a 0.39% change compared to the prior day closing price) with a volume of 96.52K shares and market capitalization of 12.64M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 93 people. Calithera Biosciences Inc. CEO is Susan M. Molineaux.

The one-year performance of Calithera Biosciences Inc. stock is 21.6%, while year-to-date (YTD) performance is 290.86%. CALA stock has a five-year performance of -82.95%. Its 52-week range is between 2.31 and 49.8, which gives CALA stock a 52-week price range ratio of 0.61%

Calithera Biosciences Inc. currently has a PE ratio of -0.10, a price-to-book (PB) ratio of 3.07, a price-to-sale (PS) ratio of 26.93, a price to cashflow ratio of 14.70, a PEG ratio of 2.32, a ROA of -140.28%, a ROC of -222.68% and a ROE of -253.05%. The company’s profit margin is -%, its EBITDA margin is -588.20%, and its revenue ttm is $9.75 Million , which makes it $0.10 revenue per share.

Of the last four earnings reports from Calithera Biosciences Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-2.70 for the next earnings report. Calithera Biosciences Inc.’s next earnings report date is 04th Aug 2022.

The consensus rating of Wall Street analysts for Calithera Biosciences Inc. is Moderate Buy (1.67), with a target price of $33.33, which is +1 181.92% compared to the current price. The earnings rating for Calithera Biosciences Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Calithera Biosciences Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Calithera Biosciences Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 16.62, ATR14 : 0.24, CCI20 : 98.61, Chaikin Money Flow : -0.08, MACD : 0.63, Money Flow Index : 62.93, ROC : 1 200.00, RSI : 81.47, STOCH (14,3) : 90.78, STOCH RSI : 0.10, UO : 75.11, Williams %R : -9.22), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Calithera Biosciences Inc. in the last 12-months were: Christopher J. Molineaux (Buy at a value of $84 670), Jonathan G. Drachman (Buy at a value of $171 900), Keith Orford (Sold 51 810 shares of value $43 520 ), Susan M. Molineaux (Buy at a value of $84 670)